COVID-19 updates - Get the latest information about Coronavirus and Iowa Heart Center

Guide HF

Purpose of Study

The CardioMEMS HF System will be used in this clinical trial to assess the effectiveness of pulmonary arterial pressure-guided HF management in a patient population that is not currently indicated, but are at risk for future heart failure events

Trial Status


Eligibility Criteria

The intended population for this clinical trial includes patients over the age of 18 with symptomatic NYHA class II, III, or IV heart failure and either a prior heart failure hospitalization within the past 12 months and/or elevated NT-proBNP (or BNP) within 30 days prior to consent

Duration of Participation

Approximately 1 year

Contact Name: Azra Cavlovic, RN

Contact Phone: 515-235-5089

Contact Email: